Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines
/in Dendritic Cells, International PublicationsPersonalized dendritic cell-based tumor immunotherapy
/in Dendritic Cells, International PublicationsClinical applications of a peptide-based vaccine for glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic cell vaccines for brain tumors
/in Dendritic Cells, Glioblastoma, International PublicationsGeneration of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
/in Dendritic Cells, International Publications, Multiple MyelomaIdentification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy
/in Dendritic Cells, International PublicationsHeat shock proteins in glioblastomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International PublicationsClinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
/in Colorectal Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer